KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Equity: 2011-2025

Historic Return on Equity for Pacira BioSciences (PCRX) over the last 15 years, with Sep 2025 value amounting to 0.03%.

  • Pacira BioSciences' Return on Equity rose 14.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 14.00%. This contributed to the annual value of -0.12% for FY2024, which is 17.00% down from last year.
  • Per Pacira BioSciences' latest filing, its Return on Equity stood at 0.03% for Q3 2025, which was up 117.63% from -0.16% recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Return on Equity registered a high of 0.26% during Q2 2021, and its lowest value of -0.16% during Q2 2025.
  • Moreover, its 3-year median value for Return on Equity was -0.01% (2023), whereas its average is -0.03%.
  • In the last 5 years, Pacira BioSciences' Return on Equity climbed by 29bps in 2021 and then decreased by 24bps in 2025.
  • Quarterly analysis of 5 years shows Pacira BioSciences' Return on Equity stood at 0.06% in 2021, then decreased by 4bps to 0.02% in 2022, then grew by 3bps to 0.05% in 2023, then fell by 18bps to -0.13% in 2024, then rose by 14bps to 0.03% in 2025.
  • Its Return on Equity was 0.03% in Q3 2025, compared to -0.16% in Q2 2025 and -0.13% in Q1 2025.